ARON 3D_Transparent

Publications

All our publications
0 3 1

First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study

Roviello
Roviello et al. Cancer Immunol Immunother
2025
09

Impact of time-of-day administration of immunotherapy on survival in metastatic renal cellcarcinoma: the MOUSEION-09 meta-analysis

Alessandro Rizzo
et al. Clin Exp Metastasis
2024
0 3

Metastatic sites and clinical outcomes in renal cell carcinoma patients receiving immune-based combinations: the MOUSEION-08 study

Alessandro Rizzo
et al. Clin Exp Metastasis
2024
MOUSEION 07

Sex differences in adverse events among cancer patients receiving immune checkpointinhibitors: the MOUSEION-07 systematic review and meta-analysis

Elsa Vitale
Elsa Vitale et al. Sci Rep
2024
MOUSEION 06

The impact of ECOG performance status on efficacy of immunotherapy and immune-basedcombinations in cancer patients: the MOUSEION-06 study

Veronica Mollica
et al. Clin Exp Med
2023
MOUSEION 05

Hypertransaminasemia in cancer patients receiving immunotherapy and immune-basedcombinations: the MOUSEION-05 study

Alessandro Rizzo
et al. Cancer Immunol Immunother
2023

Do you want to join us ?

Join us today
ARON 3D_Transparent
Youtube Linkedin

Coordinated and designed by Atteggiamento Digitale .

Legal and Privacy.